TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Neuland Laboratories Ltd. ( (IN:NEULANDLAB) ) is now available.
Neuland Laboratories Ltd. has announced a postal ballot notice seeking shareholder approval for the re-designation of key executive positions within the company. Mr. Davuluri Sucheth Rao is proposed to be re-designated as Executive Vice Chairman, and Mr. Davuluri Saharsh Rao as Chief Executive Officer & Managing Director. This move is part of the company’s strategic management restructuring, potentially impacting its operational leadership and signaling a shift in its corporate governance structure. The voting process will be conducted through remote e-voting, facilitated by NSDL, ensuring all members can participate electronically.
More about Neuland Laboratories Ltd.
Neuland Laboratories Ltd. operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company is known for its expertise in complex chemistry and caters to a global market, providing essential components for various medications.
Average Trading Volume: 7,643
Technical Sentiment Signal: Strong Buy
Current Market Cap: 195.1B INR
Learn more about NEULANDLAB stock on TipRanks’ Stock Analysis page.